NCT00831025View on ClinicalTrials.gov

Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Olea Europaea Pollen

PHASE3CompletedINTERVENTIONAL
Enrollment

158

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
Rhinitis or Rhinoconjunctivitis With or Without Asthma Induced by Hypersensitivity to Olea Europea Pollen
Interventions
BIOLOGICAL

Immunotherapy with modified extract of Olea europaea pollen

Subcutaneous immunotherapy with modified extract of Olea europaea. A subcutaneous monthly treatment.

BIOLOGICAL

Placebo

Placebo for subcutaneous monthly administration

Trial Locations (7)

14004

Hospital Universitario Reina Sofía, Córdoba

18012

Hospital Universitario San Cecilio, Granada

23007

Complejo Hospitalario de Jaén, Jaén

41013

Hospital Universitario Virgen Del Rocio, Seville

41018

Clínica Santa Isabel, Seville

41071

Hospital Virgen Macarena, Seville

41700

Hospital El Tomillar, Dos Hermanas

Sponsors
All Listed Sponsors
lead

Laboratorios Leti, S.L.

INDUSTRY

NCT00831025 - Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Olea Europaea Pollen | Biotech Hunter | Biotech Hunter